Novel therapeutic agents in clinical development for systemic lupus erythematosus
Conventional immunosuppressive therapies have radically transformed patient survival in systemic lupus erythematosus (SLE), but their use is associated with considerable toxicity and a substantial proportion of patients remain refractory to treatment. A more comprehensive understanding of the comple...
Saved in:
Published in | BMC medicine Vol. 11; no. 1; p. 120 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
03.05.2013
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!